[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"complication-of-surgical-procedure\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:complication-of-surgical-procedure":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,50,80,104,134,163,192,223],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100454296","acute-acute-surgical-care--risk-factors-and-outcomes-for-patients-in-need-of-acute-surgical-care-100454296",false,"NCT05195697","ACUTE-Acute Surgical Care- Risk Factors and Outcomes for Patients in Need of Acute Surgical Care","ACUTE","Inclusion Criteria: Patients admitted to Skåne University hospital in need of acute surgical care -\n\nExclusion Criteria: Below 18 years old\n\n\\-","ALL","18 Years",{"count":19,"type":20},3000,"ESTIMATED","OBSERVATIONAL","Observational retrospective study of patients in need of acute surgical care admitted to Skåne University Hospital between 2009 and 2019.",[24,25,26,27,28,29],"Risk Factors","Complication of Surgical Procedure","Complication of Treatment","Complication of Anesthesia","Long Term Effects After Emergency Surgery","Long Term Effects After GI Bleeding",[31,32,33,34,35,36],"Emergency surgery","Acute surgery","Complications","Risk factors","Frailty","Ageing","RECRUITING","2026-06-15",{"date":40,"type":41},"2026-06-17","ACTUAL",{"date":43,"type":41},"2020-01-01",{"date":45,"type":20},"2030-12",{"name":47,"class":48},"Region Skane","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":49},"100515542","pancreaticoduodenectomies-with-complete-arterial-coverage-by-retromesenteric-omentoplasty-100515542","NCT05992857","Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty","Randomized Controlled Trial Comparing Pancreaticoduodenectomies With or Without Complete Arterial Coverage by Omentoplasty in Patients With High Risk of Postoperative Pancreatic Fistula.","PACOMARCO","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patients requiring a pancreaticoduodenectomy (PD) for any indication\n* Open approach\n* Affiliation to the French public healthcare insurance\n* Fistula risk score (FRS) ≥ 7 confirmed intraoperatively\n* Ability to understand and to comply with the study protocol\n* Reconstruction with PJ and external pancreatic stent\n* Signed written informed consent\n* Inclusion is allowed for patients:\n\n  * On curative or long-term anticoagulation or aspirin (indicated for previous thromboembolic complications, heart disease, previous history of stroke)\n  * Undergoing PD with venous resection\n\nExclusion Criteria:\n\n* Presence of distant tumor deposits (liver and peritoneal metastases, and\u002For para-aortic lymph nodes metastases) reveals during intraoperative exploration for patient with malignant pancreatic or periampullary tumor.\n* Patients with previous abdominal surgery compromising completion of retromesenteric omentoplasty\n* PD with arterial resection (i.e. resection of hepatic artery, splenic artery, superior mesenteric artery, or celiac axis)\n* Laparoscopic or robotic PD\n* Reconstruction wih pancreatico-gastrostomy\n* Total pancreatectomy\n* Emergency procedure\n* Pregnant women\n* Patient under guardianship and curatorship\n* Participation in another interventional study evaluating complication after pancreaticoduodenectomy or patient still being in the exclusion period at the end of a previous study evaluating drugs.",{"count":59,"type":20},150,"INTERVENTIONAL",[62],"NA","To assess the efficacy of complete covering using retromesenteric omentoplasty vs. partial covering or no covering of peripancreatic arteries in decreasing incidence of grade B+C post-pancreatectomy hemorrhage (PPH), i.e. treated by transfusion and \u002F or radiological or surgical hemostasis after PD in patients with high risk of POPF.",[65,25],"Pancreatectomy",[67,68,69,70],"Pancreaticoduodenectomy","Post-pancreatectomy haemorrhage","Omentoplasty","Post-operative pancreatic fistula","2025-11-17",{"date":73,"type":41},"2025-11-18",{"date":75,"type":41},"2024-10-22",{"date":77,"type":20},"2027-01",{"name":79,"class":48},"Assistance Publique - Hôpitaux de Paris",{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":88,"minAge":17,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":91,"conditions":92,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":49},"100543130","feasibility-study-to-evaluate-the-use-of-patient-reported-complications-after-digital-consent-100543130","NCT06351865","Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent","A Feasibility Study to Evaluate if Breast Cancer Patients, Consented Using Digital Consent, Reliably Provide Accurate Patient Reported Complication (PRC) Data Using Feedback Questionnaires","PRC","Inclusion Criteria:\n\n* Consent form 1- Adult patients who have the capacity to consent for themselves.\n* Female adult aged 18years or above\n* Diagnosed with early invasive breast cancer suitable for breast conserving surgery\n* Undergoing Wide Local Excision of the breast and sentinel lymph node biopsy.\n* Participant must be able to fill out an electronic questionnaire or take part in a phone questionnaire.\n* Participant is willing and able to give informed consent for participation in the study.\n\nExclusion Criteria:\n\n* Unable to consent for themselves or do not wish to participate.\n* Patients who need an interpreter.","FEMALE",{"count":90,"type":20},50,"Patient report complication data to our best knowledge has not been studied yet in electronic consent. This study is a feasibility study to assess whether patients will reliably report their complications, the quality of this reporting and whether the information provided in the consent form matches up to their experience. This data will then be used to improve the consent process and evaluate whether the Patient Initiated Follow Up (PIFU) model is effective or if it leads to underreporting of problems.",[93,25],"Breast Cancer","2025-07-14",{"date":96,"type":41},"2025-07-17",{"date":98,"type":41},"2024-03-07",{"date":100,"type":20},"2025-10-31",{"name":102,"class":103},"Portsmouth Hospitals NHS Trust","OTHER_GOV",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":110,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":88,"minAge":17,"maxAge":4,"enrollmentInfo":112,"targetDuration":4,"studyType":60,"phases":114,"briefSummary":115,"conditions":116,"keywords":119,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":49},"100562816","study-of-the-vascularization-of-the-vaginal-slice-after-total-laparoscopic-hysterectomy-using-indocyanine-green-injection-100562816","NCT06608082","Study of the Vascularization of the Vaginal Slice After Total Laparoscopic Hysterectomy, Using Indocyanine Green Injection.","Study of the Vascularization of the Vaginal Slice After Total Laparoscopic Hysterectomy, Using Indocyanine Green Injection. Prospective Feasibility Study","HYSTINDO","Inclusion Criteria:\n\n* Adult patient\n* Patient scheduled to undergo total hysterectomy through a surgically accessible laparoscopic procedure.\n* Patiente capable of providing informed consent to participate in the study.\n* Patiente covered by the Social Security system.\n\nExclusion Criteria:\n\n* Protected patient, under guardianship, curatorship or legal protection.\n* Patient's refusal or inadequate understanding of the French language.\n* Known allergy to iodine.\n* Ongoing pregnancy and breastfeeding.\n* Procedure requiring the use of indocyanine green.",{"count":113,"type":20},90,[62],"Hysterectomy is one of the most common surgical procedures in gynecology, especially by laparoscopy. Post-operative complications of hysterectomy are numerous and their causes are poorly understood.\n\nIndocyanine green is a fluorescent dye that, when exposed to infrared light, makes it possible to visualize the vascularization by fluorescence.\n\nThe project consists in studying the vascularization of the vaginal cuff after total laparoscopic hysterectomy using the injection of indocyanine green. This is a prospective feasibility study.\n\nDuring the procedure, after performing the hysterectomy, indocyanine green will be injected intravenously into the patient. A fluorescence video of the vaginal cuff will be recorded. The fluorescence of the recorded images will be analyzed by fluorescence analysis software to obtain an objective value of fluorescence. The fluorescence values will be compared to the occurrence or absence of postoperative complications.\n\nThis is the first study using this imaging technique combined with indocyanine green in this surgery. This study will employ a novel objective sequential fluorescence analysis software that has already proven its effectiveness in digestive surgery. The sequential measurement of the change in fluorescence intensity visualized in the images of laparoscopy will enable the production of vaginal perfusion graphs using a video modeling tool such as the TRACKER software. This software measures the evolution of green levels in a region of interest, from which a time-fluorescence curve can be obtained. The presence of fluorescence will be defined by a fluorescence intensity value of Fmax-Fmin on the graph.",[117,118,25],"Hysterectomy","Vascularization",[120,121,122,123,124],"indocyanine green","laparoscopic hysterectomy","Post-operative complications of hysterectomy","TRACKER software","imaging technique","2024-09-20",{"date":127,"type":41},"2024-09-23",{"date":129,"type":20},"2024-09-21",{"date":131,"type":20},"2025-11-30",{"name":133,"class":48},"University Hospital, Clermont-Ferrand",{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":4,"eligibilityCriteria":140,"healthyVolunteers":141,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":142,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":144,"conditions":145,"keywords":147,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":162},"100555554","pathogenesis-of-postoperative-infections-and-biomarkers-for-early-diagnosis-of-it-100555554","NCT06513598","Pathogenesis of Postoperative Infections and Biomarkers for Early Diagnosis of it","New Studies of the Pathogenesis of Postoperative Infections and Development of Biomarkers for Early Diagnosis of Postoperative Complications","Inclusion Criteria:\n\n1. The patient is scheduled to undergo a major resection-type abdominal surgery due to cancer of the esophagus, stomach, pancreas, liver, bile ducts, colon or rectum.\n2. Patient is willing to participate.\n3. Age ≥ 18 years.\n\nExclusion Criteria:\n\n1. Pregnancy.\n2. Previous surgical resection of the digestive tract, excluding appendectomy and\u002For cholecystectomy.\n3. Anticipated operation with preventive ileostomy.\n4. The operation is planned to be performed as a matter of urgency.\n5. Antibiotic therapy ≤1 month. before surgery.\n6. Chronic inflammatory bowel disease (non-specific ulcerative colitis, Crohn's disease) or radiation or other colitis of origin.\n7. During the last year, the patient suffered from Cl. difficile colitis or was Cl. difficile carrier, had salmonellosis or others intestinal infections.\n8. During the last year, the patient used (\\> 3 months) pre-\u002Fpro-\u002F(syn)biotics.\n9. During the last year, the patient has been taking proton pump inhibitors continuously (\\> 6 months).",true,{"count":143,"type":20},200,"Infections remain a prevalent complication after major abdominal surgery. The common belief that most surgical site infections (SSIs) following elective surgery with modern antiseptic techniques are due to intraoperative contamination is still not confirmed. Therefore, alternative mechanisms for SSI development, such as the Trojan Horse theory-which suggests that pathogens from distant sites like the gastrointestinal tract may cause postoperative infections-should be explored. This study aims to analyze the preoperative microbiome of surgical patients' gut and oral cavities and assess whether microorganisms found there are present at the infection site. Additionally, this study will investigate a panel of biomarkers for predicting postoperative infections.",[25,146],"Infections",[148,149,150,151,152],"microbiota","surgical oncology","gastrointestinal cancer","postoperative complications","biomarkers","2024-07-30",{"date":155,"type":41},"2024-08-01",{"date":157,"type":41},"2024-07-01",{"date":159,"type":20},"2029-05-01",{"name":161,"class":48},"National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos",2,{"id":164,"slug":165,"hasResults":11,"nctId":166,"briefTitle":167,"officialTitle":168,"acronym":169,"eligibilityCriteria":170,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":171,"enrollmentInfo":172,"targetDuration":4,"studyType":60,"phases":174,"briefSummary":175,"conditions":176,"keywords":179,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":49},"100531407","safety-and-efficacy-of-xj-procedure-in-patients-with-acute-type-a-aortic-dissection-surgery-100531407","NCT06199401","Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery","Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery (ADVANCED-XJ-Ⅱ): A National, Multi-center, Open-label, Randomized, Controlled, Blinded-end Point Trial","ADVANCED-XJ-Ⅱ","Inclusion Criteria:\n\n* Age 18-70 years;\n* Patients with ATAAD attending the relevant department who have been assessed by a clinician as needing \"Sun's procedure\".\n\nExclusion Criteria:\n\n* Severe aortic root involvement (root diameter \\>45 mm, root tear, severe destruction of the aortic root, combined valve disease);\n* Combined coronary artery disease requiring concomitant coronary revascularization;\n* Prior aortic or cardiac surgery;\n* Preoperative severe malperfusion syndromes such as: severe cerebral complications (acute cerebral infarction, cerebral hemorrhage, coma, etc.); malperfusion of abdominal organs or lower extremities \\>12 h;\n* Preoperative combination of severe single or multiple organ failure;\n* Pregnant women;\n* Refused to sign the informed consent form and refused to participate in this study.","70 Years",{"count":173,"type":20},680,[62],"This is a national, multicenter, open-label, randomized, controlled, endpoint-blinded clinical trial of patients diagnosed with ATAAD and undergoing \"Sun's procedure\" coordinated by the First Affiliated Hospital of Xi'an Jiaotong University, China. Per the protocol, \"Sun's procedure\" combined with \"XJ-Procedure\" in the anastomosis of the aortic root and Sun's procedure combined with regular suturing methods of the aortic root will be compared.",[177,25,178],"Type A Aortic Dissection","Aortic Diseases",[177,180,181,182],"Aortic Root Reinforcement","Cardiovascular Surgery","Postoperative Complication","2024-07-10",{"date":185,"type":41},"2024-07-12",{"date":187,"type":41},"2024-01-11",{"date":189,"type":20},"2027-12-01",{"name":191,"class":48},"First Affiliated Hospital Xi'an Jiaotong University",{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":198,"eligibilityCriteria":199,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":171,"enrollmentInfo":200,"targetDuration":4,"studyType":60,"phases":202,"briefSummary":204,"conditions":205,"keywords":209,"overallStatus":213,"whyStopped":4,"lastUpdateSubmitDate":214,"lastUpdatePostDateStruct":215,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":221,"locationsCount":4},"100534742","phase-3-vertical-ridge-augmentation-strategies-100534742","NCT06242782","Vertical Ridge Augmentation Strategies","Vertical Ridge Augmentation Strategies: An Adaptive Randomised Controlled Clinical Trial","VARGAS","Inclusion Criteria:\n\n1. Partially edentulous with a ridge that shows at least 3mm vertical bone deficiency;\n2. Females of childbearing potential and males agree to use an effective method of contraception from the time consent is signed until treatment discontinuation.\n3. Females of childbearing potential have a negative pregnancy test within 7 days prior to being registered. Participants are considered not of child bearing potential if they are surgically sterile (i.e. they have undergone a hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or they are postmenopausal.\n4. Willing and able to provide written informed consent.\n\nExclusion Criteria:\n\n1. Comorbidities (or regular use of medications)\n2. History of bone augmentation or implant placement at the area of interest\n3. Females who are pregnant, planning pregnancy or breastfeeding\n4. Regular use of analgesic or antibiotics within 1 month before entering the study\n5. Disclosed smoking (including electronic cigarettes) or drinking over 14 alcoholic units per week\n6. Active oral diseases or poor oral hygiene (defined by full mouth dental plaque scores greater than 25%)\n7. Suspected or documented titanium allergy or intolerance\n8. Concurrent and\u002For recent involvement in other research that is likely to interfere with the intervention within last 3 months of study enrolment",{"count":201,"type":20},148,[203],"PHASE3","Guided Bone Regeneration (GBR) is an invaluable and beneficial surgical technique adopted when there is the need to augment an alveolar atrophy. Strong clinical and histologic evidence exists on the effectiveness and predictability of GBR in bone augmentation of ridge deficiencies. On the other hand, it is well known that GBR remains a challenge as in the most extreme cases, it is considered a highly technique-sensitive surgical procedure.\n\nWhilst there are numerous reviews which report the average incidence of complications in GBR, there is still insufficient evidence and manuscripts reporting a direct correlation between a specific biomaterial (membrane or scaffold) and observed complications. Only one recent systematic review and meta-analysis focused on wound healing complications following GBR for ridge augmentation procedures. Authors explored the complication rate based on the membrane type and on the timing of the first sign of soft tissue complications following bone augmentation procedures. They reported a complication rate of 17% of the overall soft tissue complications, including membrane exposure, soft tissue dehiscence, and acute infection (abscess). This estimate is consistent with that reported (12%) in a more recent systematic appraisal of the evidence on all types of complications in GBR (3). However, when horizontal augmentation procedures were reviewed, a higher rate (21%) of complications was reported within the first 18 months of a GBR procedure. This estimate was inclusive of all possible biologic complications following GBR whilst the rate of membrane exposure was of 23%.\n\nVertical bone augmentation represents one of the most challenging bone regenerative procedures in surgical dentistry. This is because of the inherent difficulties of the surgical procedure and the high risk of complications. The primary aim of this procedure is to recreate alveolar bone in a vertical direction (without the support of any pre-existing walls) and enable recreation of a more favourable anatomy for the restoration of the edentulous site.\n\nEvidence on a variety of treatment options has been produced over the last 15 years including distraction osteogenesis, onlay bone grafting, and vertical ridge augmentation (VRA). Systematic reviews evaluating the efficacy of different surgical procedures for VRA either in a staged or a simultaneous fashion, reported a range of vertical bone gain of 2-8 mm. This gain was gradually lost (1.27 to 2.0mm) between 1 to 7 years post-surgery and a wide range of complications (0- 45.5%) has been reported.\n\nThe aim of this study is to assess and compare incidence of complications and percentage of vertical bone gain when using four different barrier membranes in combination with 50\u002F50 autogenous and xenogenous bone material in VRA procedures. Secondary aims will be to evaluate and compare early and late soft tissue wound healing, gingival microvasculature and structure, patient reported outcomes and the prevalence of need for further bone augmentation and need for soft tissue grafting. Additionally, this study will also aim to assess and compare histomorphometry and histochemistry analyses of core biopsies obtained before implant placement between the four different barrier membranes.",[206,207,208,25],"Alveolar Bone Resorption","Alveolar Ridge Trauma","Alveolar Bone Loss",[210,211,212],"Vertical Ridge Augmentation","Vertical Bone Augmentation","Alveolar Bone Grafting","NOT_YET_RECRUITING","2024-02-02",{"date":216,"type":41},"2024-02-05",{"date":218,"type":20},"2024-02",{"date":220,"type":20},"2030-02",{"name":222,"class":48},"University College, London",{"id":224,"slug":225,"hasResults":11,"nctId":226,"briefTitle":227,"officialTitle":228,"acronym":4,"eligibilityCriteria":229,"healthyVolunteers":11,"sex":16,"minAge":230,"maxAge":231,"enrollmentInfo":232,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":233,"conditions":234,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":237,"lastUpdatePostDateStruct":238,"startDateStruct":240,"completionDateStruct":242,"leadSponsor":243,"locationsCount":49},"100464421","nrp-vs-dhope-vs-cor-nmp-in-ecd-dcd-donation-100464421","NCT05327478","NRP vs DHOPE vs COR-NMP in ECD-DCD Donation","Direct Comparison of NRP With DHOPE and COR-NMP to Maximize the Use of ECD After DCD Donation in the Netherlands","Inclusion criteria:\n\n* DCD donor (Maastricht type III and V)\n* Age above 50 years old and below 75 years old\n\nExclusion criteria:\n\n* Malignancy (except for primary non-metastatic central nervous system tumors, non-melanoma skin tumors or cured malignancies)\n* Active infection (sepsis, meningitis, human immune deficiency virus, rubella, rabies, herpes zoster, tuberculosis)\n* Intravenous drug abuse\n* Unknown cause of death\n* In the case of a NRP procedure: donors with a BMI above 35 and transaminases above 1000 U\u002FI and not decreasing prior to donation are excluded","50 Years","75 Years",{"count":59,"type":20},"There is still a discrepancy between the number of liver transplant candidates and the availability of liver grafts, resulting in waiting list mortality. To increase the supply of suitable liver grafts, extended-donor criteria allografts can be used. However, in the case of donation after cardiac death this is not without a risk. Donor after cardiac death (DCD) grafts have increased risk of primary non function and biliary complications, resulting in either retransplantation, patient morbidity or patient death. Due to uncertainty of their quality DCD grafts can be discarded. However, normothermic machine perfusion (NRP) has the potential to overcome these disadvantages of DCD liver grafts. In DCD livers the physiological abdominal circulation is simulated with in vivo, normothermic, oxygenated perfusion during the first two hours after cardiac death. With this perfusion technique, early ischemia can be reversed, surgical damage due to a hasty procedure can be prevented and organs can be tested on viability. In many countries, NRP is obligatory, however this is not the current golden standard in the Netherlands. The primary objective of this study is the utilization of livers after NRP. Secondary study parameters are reasons for graft discard or rejection at proposal, patient- and graft survival, biliary complications, cost assessment of NRP and outcomes of kidney and pancreas transplants. This multicenter, observational study will be performed on adult liver transplant recipients who have been allocated a DCD liver graft (Maastricht type III and V) of a donor above fifty years old. According to current national procurement protocol, grafts procured in region west will be retrieved with NRP followed by dual hypothermic oxygenated perfusion (DHOPE). Grafts retrieved in region East\u002FNorth will be retrieved using standard rapid retrieval followed by DHOPE, if the donor is aged 50-60. Grafts from donors aged above 60 will undergo controlled oxygenated rewarming normothermic machine perfusion (COR-NMP) after DHOPE.",[235,236,25],"Liver Transplant","Organ Perfusion","2022-04-11",{"date":239,"type":41},"2022-04-14",{"date":241,"type":41},"2022-01-01",{"date":159,"type":20},{"name":244,"class":48},"Erasmus Medical Center"]